Psychoses, related disorders and side effects Flashcards
Summarse the advice provided by the Royal College of Psychiatrists on doses of antipsychotic drugs above BNF upper limit (unlicensed) (7)
1) Consider alternative approaches and newer or second-generation antipsychotics such as clozapine
2) Bear in mind risk factors, including obesity; caution is indicated in older patients, especially > 70 years
3) Consider potential for drug interactions
4) Carry out ECG to exclude abnormalities e.g. prolonged QT interval; repeat ECG periodically and reduce dose if prolonged QT interval or other cardiac abnormality develop
5) Increase dose slowly and not more often than once weekly
6) Regular pulse, BP, and temperature checks; ensure that patient maintains adequate fluid intake
7) High-dose therapy to be for limited period and review regularly; abandon if no improvement after 3 months
1) When prescribing an antipsychotic for administration on an emergency basis, how will the dose of the IM drug differ from that of the corresponding oral formulation?
2) what information needs to be specified on the Rx
3) how often should the dose be reviewed for an emergency?
1) IM dose should be lower than the oral dose, (esp if patient is very active due to increased blood flow in muscles leads to increased drug absorption)
2) Specify dose for each route
3) The dose for emergency use reviewed at least daily
list the negative and positive symptoms of schizophrenia
1) Positive psychotic symptoms : Thought disorder, hallucinations, and delusions
2) Negative symptoms: Apathy and social withdrawal
1) Antipsychotic drugs are effective at relieving what type of symptoms in schizophrenia?
2) which patents respond better to antipsychotic drugs; those with acute or chronic schizophrenia?
1) Effective at relieving positive psychotic symptoms, less effective on negative symptoms
2) Those with acute generally respond better
why is early treatment of psychotic illness beneficial?
May protect against the development of negative symptoms over time
Outline the MoA of the first-generation antipsychotic drugs and explain what side effects they are known to cause.
1) Act predominantly by blocking dopamine D2 receptors in the brain
2) not selective for any of the 4 dopamine pathways so cause many side-effects especially extrapyramidal symptoms and elevated prolactin
Phenothiazine derivatives are first-generation antipsychotics which can be divided into 3 main groups. state which drugs are present in each group and the characteristics of each group.
1) Group 1: chlorpromazine , levomepromazine, promazine - pronounced sedative effects and moderate antimuscarinic and extrapyramidal side-effects
2) Group 2: pericyazine, moderate sedative effects, but fewer extrapyramidal effects than groups 1 or 3
3) Group 3: fluphenazine decanoate, perphenazine, prochlorperazine, and trifluoperazine, fewer sedative and antimuscarinic effects, but more extrapyramidal side-effects than groups 1 and 2
Butyrophenones (benperidol and haloperidol) resemble which phenothiazine derivative group with regards to their properties?
Resemble group 3 in their clinical properties- fewer sedative and antimuscarinic effects, but more extrapyramidal side-effects
How do second generation antipsychotics (atypical antipsychotic ) differ from first generation drugs?
1) 2nd generation block D2 receptors, but also block 5HT2A receptors - more distinct clinical profiles and side-effects
2) 2nd gen: Higher risk of metabolic side effects vs 1st gen: higher risk of neurological side effects
Risks vs benefit should be considered before prescribing antipsychotic drugs in elderly patients. Explain why caution is especially important in this group
1) Patients with dementia, there is a small increased risk of mortality and an increased risk of stroke or TIA
2) susceptible to postural hypotension and to hyper- and hypothermia
what are the three recommendations regarding prescribing antipsychotic drugs in the elderly?
1) Not be used to treat mild to moderate psychotic symptoms
2) Initial doses should be reduced (half the adult dose or less), considering factors such as the patient’s weight, co-morbidity, and concomitant medication
3) Treatment should be reviewed regularly
In those learning disabilities who are prescribed antipsychotic drugs and not experiencing psychotic symptoms, what considerations should be taken into account? (4)
1) a reduction in dose or the discontinuation of long-term antipsychotic treatment
2) review condition after dose reduction/discontinuation
3) referral to a psychiatrist experienced in working with patients who have learning disabilities and mental health
4) Annual documentation of the reasons for continuing a the antipsychotic if not dose reduced/discontinued
which antipsychotic drugs are most frequently known for causing extrapyramidal symptoms?
1) The butyrophenones (benperidol and haloperidol)
2) Piperazine phenothiazines (fluphenazine, perphenazine, prochlorperazine, and trifluoperazine)
3) First-generation depot preparations
Outline the 4 different types of extrapyramidal symptoms
1) Parkinsonian symptoms (including tremor), more commonly in adults or elderly and may appear gradually
2) Dystonia (abnormal face/ body movements) and dyskinesia. Commonly in children or young adults and appear after only a few doses
3) Akathisia (restlessness), Occurs after large initial doses
4) Tardive dyskinesia (rhythmic, involuntary movements of tongue, face, and jaw), Develops on long-term therapy or with high dosage. short-lived tardive may occur after withdrawal of the drug
outline how parkinsonian symptoms caused by antipsychotics can be managed
1) Remit if the drug is withdrawn and may be suppressed by the administration of antimuscarinic drugs
2) Routine use of antimuscarinic not justified as not everyone is affected and they may unmask or worsen tardive dyskinesia